Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 630 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 860 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 860 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10995072 (2021) BindingDB Entry DOI: 10.7270/Q2D79FJQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.58E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10995072 (2021) BindingDB Entry DOI: 10.7270/Q2D79FJQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.54E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Inositol monophosphate (IP1) production were measured in 1321N1 cells stably expressing human PAR2 using an IP-One HTRF assay kit (Cisbio). 80 nl of ... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Proteinase-activated receptor 2 (Homo sapiens (Human)) | BDBM429569 (US10550089, Example 43 | US10550089, Example 44 | ...) | PDB Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >4.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Heptares Therapeutics Limited US Patent | Assay Description Calcium mobilization was measured using 1321N1 cells stably expressing human PAR2. Cells were seeded in 384-well plates at 4,000 cells per well in 20... | US Patent US10550089 (2020) BindingDB Entry DOI: 10.7270/Q2SB484T | |||||||||||
More data for this Ligand-Target Pair |